Search

Search results

Retina UK awards new research funding

Retina UK is delighted to have awarded a new three-year research grant to Prof Majlinda Lako at Newcastle University for a project entitled: To establish AAV.PRPF31 gene augmentation in PRPF31-deficient RPE and photoreceptor cells and assess its efficacy in restoring RPE and photoreceptor function.

Elena Piotter

Meet a Researcher: Elena Piotter

Nurturing a new generation of scientists is a vital investment in the future of retinal disease research, so we are delighted to be funding, in collaboration with the Macular Society, a new PhD studentship at Oxford University, supervised by Professor Robert MacLaren.

A high power image showing the position of a single transplanted photoreceptor cell (green) making new connections with bipolar cells in the recipient retina (cyan).

Stem cells

Stem cells are a special type of cell, which under the right conditions can be encouraged to grow into any other type of cell in the body, including retinal cells (rods, cones and retinal pigment epithelial cells).

A man facing towards the camera seated with a woman facing away from the camera (towards the man)

Types of inherited sight loss

Inherited progressive sight loss is caused by a range of rare genetic conditions. We specialise in those which affect the retina.

Woman in lab coat plating

Medical research

Retina UK has invested more than £16million into cutting-edge research since the charity was founded in 1976.

New ‘vision’ and identity sight loss charities

The collective partnership of eight of the leading charities in the sight loss sector, known for the last three years as the VI Charity Sector Partnership, has re-launched under a new identity of the ‘Vision Partnership’ with a re-invigorated purpose and new strategic focus.

A handshake

Our Partners

We are proud to work collaboratively with a number of corporate partners to enable our community to live fulfilled lives today as well as supporting the pharmaceutical industry in their mission to develop potential new treatments.